Metal-on-metal hip resurfacing arthroplasty: A review of periprosthetic biological reactions

Acta Orthopaedica

Volumn 79, Issue 6, 2008, Pages 734-747

  Mabilleau, Guillaume ^a   Kwon, Young Min ^a   Pandit, Hemant ^a   Murray, David W ^a   Sabokbar, Afsie ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; CHROMIUM; COBALT; METAL ION;

BONE CELL; HIP ARTHROPLASTY; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; ION TRANSPORT; JOINT STABILITY; MEDICAL LITERATURE; METAL ON METAL HIP RESURFACING ARTHROPLASTY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PROSTHESIS MATERIAL; REVIEW;

AGE FACTORS; ARTHROPLASTY, REPLACEMENT, HIP; CHROMIUM; COBALT; DRUG HYPERSENSITIVITY; HUMANS; METALS, HEAVY; MOLYBDENUM; OSTEOARTHRITIS, HIP; OSTEOLYSIS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; SYNOVIAL FLUID;

EID: 57749103935     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.1080/17453670810016795     Document Type: Review

References (120)

1. Allen M J et al. The effects of particulate cobalt, chromium and cobalt-chromium alloy on human osteoblast-like cells in vitro. J Bone Joint Surg (Br) 1997; 79: 475-82.
2. Amstutz H C et al. Resurfacing THA for patients younger than 50 year: results of 2- to 9-year followup. Clin Orthop 2007; (460): 159-64.
3. Anissian L et al. Cobalt ions influence proliferation and function of human osteoblast-like cells. Acta Orthop Scand 2002; 73: 369-74.
4. Arslan P et al. Intracellular chromium reduction. Biochim Biophys Acta 1987; 931: 10-5.
5. Back D L et al. Early results of primary Birmingham hip resurfacings. An independent prospective study of the first 230 hips. J Bone Joint Surg (Br) 2005a; 87: 324-9.
6. Back D L et al. How do serum cobalt and chromium levels change after metal-on-metal hip resurfacing? Clin Orthop 2005b; (438): 177-81.
7. Bacon B R et al. Hepatic lipid peroxidation in vivo in rats with chronic iron overload. J Clin Invest 1983; 71: 429-39.
8. Bar-Or D et al. Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur J Biochem 2001; 268: 42-7.
9. Beaule P E et al. Risk factors affecting outcome of metal-on-metal surface arthroplasty of the hip. Clin Orthop 2004a; [no.??)]: 87-93.
10. Beaule P E et al. Metal-on-metal surface arthroplasty with a cemented femoral component: a 7-10 year follow-up study. J Arthroplasty 2004b; 19: 17-22.
11. Bell R S et al. A study of implant failure in the Wagner resurfacing arthroplasty. J Bone Joint Surg (Am) 1985; 67: 1165-75.
12. Boardman D R et al. A benign psoas mass following metal-on-metal resurfacing of the hip. J Bone Joint Surg (Br) 2006; 88: 402-4.
13. Borguet F et al. Study of the chromium binding in plasma of patients on continuous ambulatory peritoneal dialysis. Clin Chim Acta 1995; 238: 71-84.
14. Brodner W et al. Serum cobalt levels after metal-on-metal total hip arthroplasty. J Bone Joint Surg (Am) 2003; 85: 2168-73.
15. Brodner W et al. Does the placenta inhibit the passage of chromium and cobalt after metal-on-metal total hip arthroplasty? J Arthroplasty 2004a; 19: 102-6.
16. Brodner W et al. Cup inclination and serum concentration of cobalt and chromium after metal-on-metal total hip arthroplasty. J Arthroplasty 2004b; 19: 66-70.
17. Buergi M L, Walter W L. Hip resurfacing arthroplasty: the Australian experience. J Arthroplasty 2007; 22: 61-5.
18. Buschner G et al. Subsurface microstructure of metal-on-metal hip joints and its relationship to wear particle generation. J Biomed Mater Res 2004; 72B: 206-14.
19. Buttner B, Beyersmann D. Modification of the erythrocyte anion carrier by chromate. Xenobiotica 1985; 15: 735-41.
20. Campbell P et al. Isolation of predominantly submicron-sized UHMWPE wear particles from periprosthetic tissues. J Biomed Mater Res 1995; 29: 127-31.
21. Campbell P et al. Wear and morphology of ultra-high molecular weight polyethylene wear particles from total hip replacements. Proc Inst Mech Eng [H] 1996; 210: 167-74.
22. Case C P et al. Preliminary observations on possible premalignant changes in bone marrow adjacent to worn total hip arthroplasty implants. Clin Orthop 1996; (329): S269-79.
23. Clarke M T et al. Levels of metal ions after small- and large-diameter metal-on-metal hip arthroplasty. J Bone Joint Surg (Br) 2003; 85: 913-7.
24. Clodfelder B J et al. The trail of chromium(III) in vivo from the blood to the urine: the roles of transferrin and chromodulin. J Biol Inorg Chem 2001; 6: 608-17.
25. Cobb A G, Schmalzreid T P. The clinical significance of metal ion release from cobalt-chromium metal-on-metal hip joint arthroplasty. Proc Inst Mech Eng [H] 2006; 220: 385-98.
26. Coleman R F et al. Concentration of wear products in hair, blood, and urine after total hip replacement. Br Med J 1973; 1: 527-9.
27. Daniel J et al. Metal-on-metal resurfacing of the hip in patients under the age of 55 years with osteoarthritis. J Bone Joint Surg (Br) 2004; 86: 177-84.
28. Daniel J et al. The effect of the diameter of metal-on-metal bearings on systemic exposure to cobalt and chromium. J Bone Joint Surg (Br) 2006; 88: 443-8.
29. Daniel J et al. The validity of serum levels as a surrogate measure of systemic exposure to metal ions in hip replacement. J Bone Joint Surg (Br) 2007; 89: 736-41.
30. Davies A P et al. An unusual lymphocytic perivascular infiltration in tissues around contemporary metal-on-metal joint replacements. J Bone Joint Surg (Am) 2005; 87: 18-27.
31. De Smet K A. Belgium experience with metal-on-metal surface arthroplasty. Orthop Clin North Am 2005 ;36: 203-13, ix.
32. Dizdaroglu M et al. Free radical-induced damage to DNA: mechanisms and measurement. Free Radic Biol Med 2002; 32: 1102-15.
33. Doherty A T et al. Increased chromosome translocations and aneuploidy in peripheral blood lymphocytes of patients having revision arthroplasty of the hip. J Bone Joint Surg (Br) 2001; 83: 1075-81.
34. Doorn P F et al. Tissue reaction to metal on metal total hip prostheses. Clin Orthop 1996; (329): S187-205.
35. Doorn P F et al. Metal wear particle characterization from metal on metal total hip replacements: transmission electron microscopy study of periprosthetic tissues and isolated particles. J Biomed Mater Res 1998; 42: 103-11.
36. Dumbleton J H et al. A literature review of the association between wear rate and osteolysis in total hip arthroplasty. J Arthroplasty 2002; 17: 649-61.
37. Eitinger T et al. Secondary transporters for nickel and cobalt ions: theme and variations. Biometals 2005; 18: 399-405.
38. Eshaghi S et al. Crystal structure of a divalent metal ion transporter CorA at 2.9 angstrom resolution. Science 2006; 313: 354-7.
39. Fernandes M H. Effect of stainless steel corrosion products on in vitro biomineralization. J Biomater Appl 1999; 14: 113-68.
40. Fleury C et al. Effect of cobalt and chromium ions on human MG-63 osteoblasts in vitro: morphology, cytotoxicity, and oxidative stress. Biomaterials 2006; 27: 3351-60.
41. Galle P et al. Role of alveolar macrophages in precipitation of mineral elements inhaled as soluble aerosols. Environ Health Perspect 1992; 97: 145-7.
42. Gillespie W J et al. Development of hematopoietic cancers after implantation of total joint replacement. Clin Orthop 1996; (329): S290-6.
43. Goodman S B et al. In vitro, in vivo, and tissue retrieval studies on particulate debris. Clin Orthop 1998; (352): 25-34.
44. Green T R et al. Polyethylene particles of a 'critical size' are necessary for the induction of cytokines by macrophages in vitro. Biomaterials 1998; 19: 2297-302.
45. Grigoris P et al. The evolution of hip resurfacing arthroplasty. Orthop Clin North Am 2005; 36: 125-34, vii.
46. Gruber F W et al. Cystic lesion of the groin due to metallosis: a rare long-term complication of metal-on-metal total hip arthroplasty. J Arthroplasty 2007; 22: 923-7.
47. Hallab N J et al. A triple assay technique for the evaluation of metal-induced, delayed-type hypersensitivity responses in patients with or receiving total joint arthroplasty. J Biomed Mater Res 2000; 53: 480-9.
48. Hallab N et al. Metal sensitivity in patients with orthopaedic implants. J Bone Joint Surg (Am) 2001; 83: 428-36.
49. Hallab N J et al. Concentration- and composition-dependent effects of metal ions on human MG-63 osteoblasts. J Biomed Mater Res 2002; 60: 420-33.
50. Hallab N J et al. Lymphocyte responses in patients with total hip arthroplasty. J Orthop Res 2005; 23: 384-91.
51. Harris W H. The problem is osteolysis. Clin Orthop 1995; (311): 46-53.
52. Hart A J et al. The association between metal ions from hip resurfacing and reduced T-cell counts. J Bone Joint Surg (Br) 2006; 88: 449-54.
53. Hartwig A et al. Modulation of DNA repair processes by arsenic and selenium compounds. Toxicology 2003; 193: 161-9.
54. Head W C. Wagner surface replacement arthroplasty of the hip. Analysis of fourteen failures in forty-one hips. J Bone Joint Surg (Am) 1981; 63: 420-7.
55. Heisel C et al. The relationship between activity and ions in patients with metal-on-metal bearing hip prostheses. J Bone Joint Surg (Am) 2005; 87: 781-7.
56. Hing C B et al. The results of primary Birmingham hip resurfacings at a mean of five years: An independent prospective review of the first 230 hips. J Bone Joint Surg (Br) 2007; 89: 1431-8.
57. Hodges N J and Chipman J K. Down-regulation of the DNA-repair endonuclease 8-oxo-guanine DNA glycosylase 1 (hOGG1) by sodium dichromate in cultured human A549 lung carcinoma cells. Carcinogenesis 2002; 23: 55-60.
58. Howie D W, Vernon-Roberts B. Long-term effects of intraarticular cobalt-chrome alloy wear particles in rats. J Arthroplasty 1988; 3: 327-36.
59. Howie D W et al. The long-term wear of retrieved McKee-Farrar metal-on-metal total hip prostheses. J Arthroplasty 2005; 20: 350-7.
60. Jacobs J J et al. Cobalt and chromium concentrations in patients with metal on metal total hip replacements. Clin Orthop 1996; (329): S256-63.
61. Jacobs J J et al. Metal release in patients who have had a primary total hip arthroplasty. A prospective, controlled, longitudinal study. J Bone Joint Surg (Am) 1998; 80: 1447-58.
62. Jakobsen S S et al. Cobalt-chromium-molybdenum alloy causes metal accumulation and metallothionein up-regulation in rat liver and kidney. Basic Clin Pharmacol Toxicol 2007; 101: 441-6.
63. Kadoya Y et al. Wear and osteolysis in total joint replacements. Acta Orthop Scand (Suppl 278) 1998: 1-16.
64. Keegan G M et al. Orthopaedic metals and their potential toxicity in the arthroplasty patient: A review of current knowledge and future strategies. J Bone Joint Surg (Br) 2007; 89: 567-73.
65. Kobayashi A et al. The size and shape of particulate polyethylene wear debris in total joint replacements. Proc Inst Mech Eng [H] 1997a; 211: 11-5.
66. Kobayashi A et al. Number of polyethylene particles and osteolysis in total joint replacements. A quantitative study using a tissue-digestion method. J Bone Joint Surg (Br) 1997b; 79: 844-8.
67. Kudo O et al. Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. Bone 2003; 32: 1-7.
68. Ladon D et al. Changes in metal levels and chromosome aberrations in the peripheral blood of patients after metal-on-metal hip arthroplasty. J Arthroplasty 2004; 19: 78-83.
69. Lhotka C et al. Four-year study of cobalt and chromium blood levels in patients managed with two different metal-on-metal total hip replacements. J Orthop Res 2003; 21: 189-95.
70. Lidgren L. Chronic inflammation, joint replacement and malignant lymphoma. J Bone Joint Surg (Br) 2008; 90: 7-10.
71. Lilikakis A K et al. Hydroxyapatite-coated femoral implant in metal-on-metal resurfacing hip arthroplasty: minimum of two years follow-up. Orthop Clin North Am 2005; 36: 215-22, ix.
72. Lundborg M et al. Phagolysosomal pH and dissolution of cobalt oxide particles by alveolar macrophages. Environ Health Perspect 1992; 97: 153-7.
73. Mabilleau G et al. Influence of fluoride, hydrogen peroxide and lactic acid on the corrosion resistance of commercially pure titanium. Acta Biomater 2006; 2: 121-9.
74. MacDonald S J et al. Metal-on-metal versus polyethylene in hip arthroplasty: a randomized clinical trial. Clin Orthop 2003; (406): 282-96.
75. MacQuarrie R A et al. Wear-particle-induced osteoclast osteolysis: the role of particulates and mechanical strain. J Biomed Mater Res B Appl Biomater 2004; 69: 104-12.
76. Madan S et al. Recurrent intrapelvic cyst complicating metal-on-metal cemented total hip arthroplasty. Arch Orthop Trauma Surg 2000; 120: 508-10.
77. Maloney W J et al. Fixation, polyethylene wear, and pelvic osteolysis in primary total hip replacement. Clin Orthop 1999; (369): 157-64.
78. Margevicius K J et al. Isolation and characterization of debris in membranes around total joint prostheses. J Bone Joint Surg (Am) 1994; 76: 1664-75.
79. Marker M et al. Metal-on-metal hip implants: do they impair renal function in the long-term? A 10-year follow-up study. Arch Orthop Trauma Surg 2007; 128: 915-9.
80. Marnett L J. Lipid peroxidation-DNA damage by malondialdehyde. Mutat Res 1999; 424: 83-95.
81. McKay G C et al. Interactions of orthopaedic metals with an immortalized rat osteoblast cell line. Biomaterials 1996; 17: 1339-44.
82. McKellop H et al. In vivo wear of three types of metal on metal hip prostheses during two decades of use. Clin Orthop 1996; (329): S128-40.
83. Mont M A et al. Resurfacing hip arthroplasty: comparison of a minimally invasive versus standard approach. Clin Orthop Relat Res 2005;441: 125-31.
84. Mont M A et al. Use of metal-on-metal total hip resurfacing for the treatment of osteonecrosis of the femoral head. J Bone Joint Surg (Am) (Suppl 3) 2006; 88: 90-7.
85. Morais S et al. In vitro biomineralization by osteoblast-like cells. I. Retardation of tissue mineralization by metal salts. Biomaterials 1998; 19: 13-21.
86. National joint registry England and Wales annual report. http:www.njrventre.org.uk/Public/prev_annual_reports.htm 2008.
87. Nichols K G, Puleo D A. Effect of metal ions on the formation and function of osteoclastic cells in vitro. J Biomed Mater Res 1997; 35: 265-71.
88. Nishii T et al. Five-year results of metal-on-metal resurfacing arthroplasty in Asian patients. J Arthroplasty 2007; 22: 176-83.
89. The Norwegian Arthroplasty Register. http://www.haukeland.no/nrl 2007.
90. Pandit H et al. Pseudotumours associated with metal-on-metal hip resurfacings. J Bone Joint Surg (Br) 2008; 90: 847-51.
91. Papageorgiou I et al. The effect of nano- and micron-sized particles of cobalt-chromium alloy on human fibroblasts in vitro. Biomaterials 2007; 28: 2946-58.
92. Park Y S et al. Early osteolysis following second-generation metal-on-metal hip replacement. J Bone Joint Surg (Am) 2005; 87: 1515-21.
93. Qian Z M et al. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev 2002; 54: 561-87.
94. Rae T. The macrophage response to implant materials. Crit Rev Biocompatibility 1986; 2: 97-126.
95. Rasquinha V J et al. Serum metal levels and bearing surfaces in total hip arthroplasty. J Arthroplasty 2006; 21: 47-52.
96. Revell M P et al. Metal-on-metal hip resurfacing in osteonecrosis of the femoral head. J Bone Joint Surg (Am) (Suppl 3) 2006; 88: 98-103.
97. Robey P, Boskey A. Extracellular matrix and biomineralization. In: Primer on the metabolic bone diseases and disorders of mineral metabolism (eds Lian J, Goldring S). American Society for Bone and Mineral Research, Washington DC 2006: 12-9.
98. Rousselle A V et al. Influence of metal ion solutions on rabbit osteoclast activities in vitro. Histol Histopathol 2002; 17: 1025-32.
99. Savarino L et al. Ion release in patients with metal-on-metal hip bearings in total joint replacement: a comparison with metal-on-polyethylene bearings. J Biomed Mater Res 2002; 63: 467-74.
100. Schmalzried T P et al. Periprosthetic bone loss in total hip arthroplasty. Polyethylene wear debris and the concept of the effective joint space. J Bone Joint Surg (Am) 1992; 74: 849-63.
101. Shanbhag A S et al. Composition and morphology of wear debris in failed uncemented total hip replacement. J Bone Joint Surg (Br) 1994; 76: 60-7.
102. Shimmin A et al. Metal-on-metal hip resurfacing arthroplasty. J Bone Joint Surg (Am) 2008; 90: 637-54.
103. Shimmin A J, Back D. Femoral neck fractures following Birmingham hip resurfacing: a national review of 50 cases. J Bone Joint Surg (Br) 2005; 87: 463-4.
104. Shimmin A J et al. Complications associated with hip resurfacing arthroplasty. Orthop Clin North Am 2005; 36: 187-93, ix.
105. Sieber H P et al. Analysis of 118 second-generation metal-on-metal retrieved hip implants. J Bone Joint Surg (Br) 1999; 81: 46-50.
106. Sochart D H. Relationship of acetabular wear to osteolysis and loosening in total hip arthroplasty. Clin Orthop 1999; (363): 135-50.
107. Steffen R T et al. The five-year results of the Birmingham Hip Resurfacing arthroplasty: An independent series. J Bone Joint Surg (Br) 2008; 90: 436-41.
108. Sun H et al. Transferrin as a metal ion mediator. Chem Rev 1999; 99: 2817-42.
109. Swedish Hip Arthroplasty Register. http://www.jru.orthop.gu.se 2006.
110. Toms A P et al. MRI of early symptomatic metal-on-metal total hip arthroplasty: a retrospective review of radiological findings in 20 hips. Clin Radiol 2008; 63: 49-58.
111. Torti S V, Torti F M. Iron and ferritin in inflammation and cancer. Adv Inorg Biochem 1994; 10: 119-37.
112. Treacy R B et al. Birmingham hip resurfacing arthroplasty. A minimum follow-up of five years. J Bone Joint Surg (Br) 2005; 87: 167-70.
113. Vendittoli P A et al. Chromium and cobalt ion release following the Durom high carbon content, forged metal-on-metal surface replacement of the hip. J Bone Joint Surg (Br) 2007; 89: 441-8.
114. Virginio C et al. Effects of divalent cations, protons and calmidazolium at the rat P2X7 receptor. Neuropharmacology 1997; 36: 1285-94.
115. Wang J Y et al. Prosthetic metals impair murine immune response and cytokine release in vivo and in vitro. J Orthop Res 1997; 15: 688-99.
116. Willert H G et al. Metal-on-metal bearings and hypersensitivity in patients with artificial hip joints. A clinical and histomorphological study. J Bone Joint Surg (Am) 2005; 87: 28-36.
117. Witkiewicz-Kucharczyk A, Bal W. Damage of zinc fingers in DNA repair proteins, a novel molecular mechanism in carcinogenesis. Toxicol Lett 2006; 162: 29-42.
118. Witzleb W C et al. Neo-capsule tissue reactions in metal-on-metal hip arthroplasty. Acta Orthop 2007; 78: 211-20.
119. Wolf T et al. Molecular interaction of different chromium species with nucleotides and nucleic acids. Carcinogenesis 1989; 10: 655-9.
120. Ziaee H et al. Transplacental transfer of cobalt and chromium in patients with metal-on-metal hip arthroplasty: a controlled study. J Bone Joint Surg (Br) 2007; 89: 301-5.